Salem, MA, United States of America

Matthew Pecukonis


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Matthew Pecukonis

Introduction

Matthew Pecukonis is an accomplished inventor based in Salem, MA (US). He has made significant contributions to the field of biochemistry, particularly in the area of lectin compositions. With a total of two patents to his name, Pecukonis is recognized for his innovative approaches to reducing the mitogenicity of these compositions.

Latest Patents

Pecukonis's latest patents focus on methods for reducing the T-cell mitogenicity of lectin compositions. These methods involve chemically modifying mitogenic lectin compositions under optimized conditions. Additionally, the reduction in T-cell mitogenicity can be achieved by removing unmodified subunits from chemically modified mixtures. The modified lectin compositions with reduced T-cell mitogenicity are also provided, along with various uses for these inventive compositions.

Career Highlights

Matthew Pecukonis is currently associated with Smartcells, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the safety and efficacy of lectin-based applications in various fields.

Collaborations

Pecukonis collaborates with notable colleagues, including Thomas M Lancaster and Wenyi Cai. Their combined expertise contributes to the innovative research being conducted at Smartcells, Inc.

Conclusion

Matthew Pecukonis is a notable inventor whose work in reducing the mitogenicity of lectin compositions has the potential to impact various scientific fields. His contributions through patents and collaborations highlight his commitment to innovation and advancement in biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…